Recombinant human chitinase

Current Opinion in Anti-infective Investigational Drugs

Volumn 2, Issue 4, 2000, Pages 399-404

  Stevens, D A ^a   Brammer, H A ^a   Meyer, D W ^a   Steiner, B H ^a  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

Antifungal; Chitin; Chitinase; Drug synergy; Host defenses

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CHITIN; CHITINASE; FLUCONAZOLE; ITRACONAZOLE; N ACETYLGLUCOSAMINE; NIKKOMYCIN; POLYENE;

ANTIFUNGAL ACTIVITY; ASPERGILLUS FUMIGATUS; BLASTOMYCES DERMATITIDIS; CANDIDA ALBICANS; COCCIDIOIDES IMMITIS; CRYPTOCOCCUS NEOFORMANS; DNA LIBRARY; DRUG CAPSULE; DRUG INHIBITION; DRUG ISOLATION; DRUG POTENTIATION; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; FUNGUS; HISTOPLASMA CAPSULATUM; HUMAN; MINIMUM INHIBITORY CONCENTRATION; REVIEW;

EID: 0033859654     PISSN: 14648458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Emerging therapeutic cell wall targets in fungal infections
2. Biosynthesis of the fungall wall - Mechanisms and implications
3. Compounds active against cell walls of medically important fungi
4. Attenuated virulence of chitin-deficient mutants of Candida albicans
5. Coccidioidomycosis
6. Properties of the chitinase of the antifungal biocontrol agent Streptomyces lydicus WYEC108
7. Plant and bacterial chitinases differ in antifungal activity
8. An overview of nikkomycins: History, biochemistry, and applications
9. Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis and blastomycosis
10. Efficacy of nikkimycin Z against experimental pulmonary blastomycosis
11. Synergistic action of nikkomycin X/Z with azole antifungals on Candida albicans
12. Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo
13. Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (nikkomycin Z) for inhibition and killing of fungal pathogens
14. Structural and functional definition of the human chitinase chitin-binding domain
15. Chitinase activity in human serum and leukocytes
16. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages
17. Chitinase levels in guinea pig blood are increased after systemic infection with Aspergillus fumigatus
18. Serial chitotriosedase activity estimations in noenatal systemic candidiasis
19. Candida infections following allogeneic marrow transplantation is associated with the chitotriosidase genotype of the marrow donor
20. Effects of lysozyme and chitinase on the spherules of Coccidioides immitis in vitro
21. Mycolase, a new kind of systemic antimycotic
22. The influence of carbohydrases on the growth of fungal pathogens in vitro and in vivo
23. Mycolase II: An enzyme antifungal agent interacts with the polyene antibiotic pimaricin in the treatment of keratomycosis
24. Architecture of the yeast cell wall
25. Antifungal hydrolases in pea tissue
26. Variability in antifungal proteins in the grains of maize, sorghum and wheat
27. Lipopeptide inhibitors of fungal glucan synthase
28. Adhesion of Candida albicans to epithelial cells - Effect of nikkomycin
29. Profile of human macrophage transcripts: Insights into macrophage biology and identification of novel chemokines
30. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells
31. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts Th2 cells
32. Marked elevation of plasma chitotriosidase activity
33. In vitro antifungal activity of novel azole derivatives with a morpholine ring, UR-9746 and UR-9751, and comparison with fluconazole
34. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents
35. Analysis of variability of agar dilution-replicator method of fungal susceptibility testing
36. Standardization of a fluconazole bioassay and correlation of results obtained by high-pressure liquid chromatography
37. Anti-Cryptococcus neoformans antibodies during cryptococcosis in patients with the acquired immuno-deficiency syndrome
38. Capsule size of Cryptococcus neoformans: Control and relationship to virulence
39. Collaboration of human phagocytes with LY303366 for antifungal activity against Aspergillus fumigatus
40. Chitin and chitosan stimulate canine polymorphonuclear cells to release leukotriene B4 and protaglandin E2
41. Oral administration of chitin downregulates serum IgE levels and lung eosinophilia in the allergic mouse
42. Human enzymatic activities related to the therapeutic administration of chitin derivatives
43. Antifungal efficacy of recombinant human chitinase in murine candidiasis and aspergillosis